Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Report 2019, Competitive Landscape, Trends and Opportunities
The Chronic Obstructive Pulmonary Disease (COPD) Drugs market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Chronic Obstructive Pulmonary Disease (COPD) Drugs market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Chronic Obstructive Pulmonary Disease (COPD) Drugs market.
Major players in the global Chronic Obstructive Pulmonary Disease (COPD) Drugs market include:
MediciNova
Chiesi Farmaceutici
F. Hoffmann-La Roche
Invion
Ache Laboratorios Farmaceuticos
Mylan
Palobiofarma
Innoviva
Cytokinetics
AstraZeneca
Prosonix
Boehringer Ingelheim
Novartis
Merck
Gilead Sciences
Mereo BioPharma
Pearl Therapeutics
BioMarck Pharmaceuticals
Orion Corporation
Pharmaxis
Aquinox Pharmaceuticals
Astellas Pharma
ZAI Lab
Asmacure
Almirall
Ario Pharma
On the basis of types, the Chronic Obstructive Pulmonary Disease (COPD) Drugs market is primarily split into:
anticholinergic
oral corticosteroid
beta2-agonists
phosphodiesterase-4 (PDE4) inhibitors
others
On the basis of applications, the market covers:
lung functional test
chest x-ray test
CT scan
others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Chronic Obstructive Pulmonary Disease (COPD) Drugs market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Chronic Obstructive Pulmonary Disease (COPD) Drugs market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Chronic Obstructive Pulmonary Disease (COPD) Drugs industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Chronic Obstructive Pulmonary Disease (COPD) Drugs market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Chronic Obstructive Pulmonary Disease (COPD) Drugs, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Chronic Obstructive Pulmonary Disease (COPD) Drugs in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Chronic Obstructive Pulmonary Disease (COPD) Drugs in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Chronic Obstructive Pulmonary Disease (COPD) Drugs. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Chronic Obstructive Pulmonary Disease (COPD) Drugs market, including the global production and revenue forecast, regional forecast. It also foresees the Chronic Obstructive Pulmonary Disease (COPD) Drugs market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
The report mainly studies the size, recent trends and development status of the Chronic Obstructive Pulmonary Disease (COPD) Drugs market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Chronic Obstructive Pulmonary Disease (COPD) Drugs market.
Major players in the global Chronic Obstructive Pulmonary Disease (COPD) Drugs market include:
MediciNova
Chiesi Farmaceutici
F. Hoffmann-La Roche
Invion
Ache Laboratorios Farmaceuticos
Mylan
Palobiofarma
Innoviva
Cytokinetics
AstraZeneca
Prosonix
Boehringer Ingelheim
Novartis
Merck
Gilead Sciences
Mereo BioPharma
Pearl Therapeutics
BioMarck Pharmaceuticals
Orion Corporation
Pharmaxis
Aquinox Pharmaceuticals
Astellas Pharma
ZAI Lab
Asmacure
Almirall
Ario Pharma
On the basis of types, the Chronic Obstructive Pulmonary Disease (COPD) Drugs market is primarily split into:
anticholinergic
oral corticosteroid
beta2-agonists
phosphodiesterase-4 (PDE4) inhibitors
others
On the basis of applications, the market covers:
lung functional test
chest x-ray test
CT scan
others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Chronic Obstructive Pulmonary Disease (COPD) Drugs market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Chronic Obstructive Pulmonary Disease (COPD) Drugs market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Chronic Obstructive Pulmonary Disease (COPD) Drugs industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Chronic Obstructive Pulmonary Disease (COPD) Drugs market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Chronic Obstructive Pulmonary Disease (COPD) Drugs, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Chronic Obstructive Pulmonary Disease (COPD) Drugs in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Chronic Obstructive Pulmonary Disease (COPD) Drugs in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Chronic Obstructive Pulmonary Disease (COPD) Drugs. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Chronic Obstructive Pulmonary Disease (COPD) Drugs market, including the global production and revenue forecast, regional forecast. It also foresees the Chronic Obstructive Pulmonary Disease (COPD) Drugs market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
- Historical Years: 2014-2018
- Base Year: 2019
- Estimated Year: 2019
- Forecast Period: 2019-2026
1 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Chronic Obstructive Pulmonary Disease (COPD) Drugs
1.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Segment by Type
1.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of anticholinergic
1.2.3 The Market Profile of oral corticosteroid
1.2.4 The Market Profile of beta2-agonists
1.2.5 The Market Profile of phosphodiesterase-4 (PDE4) inhibitors
1.2.6 The Market Profile of others
1.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Segment by Application
1.3.1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of lung functional test
1.3.3 The Market Profile of chest x-ray test
1.3.4 The Market Profile of CT scan
1.3.5 The Market Profile of others
1.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market by Region (2014-2026)
1.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.3.1 Germany Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.3.2 UK Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.3.3 France Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.3.4 Italy Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.3.5 Spain Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.3.6 Russia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.3.7 Poland Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.4 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.5 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.6 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.8 Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Chronic Obstructive Pulmonary Disease (COPD) Drugs (2014-2026)
1.5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Status and Outlook (2014-2026)
1.5.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Status and Outlook (2014-2026)
2 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DRUGS MARKET LANDSCAPE BY PLAYER
2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and Share by Player (2014-2019)
2.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Market Share by Player (2014-2019)
2.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Average Price by Player (2014-2019)
2.4 Chronic Obstructive Pulmonary Disease (COPD) Drugs Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Competitive Situation and Trends
2.5.1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Concentration Rate
2.5.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 MediciNova
3.1.1 MediciNova Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.1.3 MediciNova Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.1.4 MediciNova Business Overview
3.2 Chiesi Farmaceutici
3.2.1 Chiesi Farmaceutici Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.2.3 Chiesi Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.2.4 Chiesi Farmaceutici Business Overview
3.3 F. Hoffmann-La Roche
3.3.1 F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.3.3 F. Hoffmann-La Roche Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.3.4 F. Hoffmann-La Roche Business Overview
3.4 Invion
3.4.1 Invion Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.4.3 Invion Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.4.4 Invion Business Overview
3.5 Ache Laboratorios Farmaceuticos
3.5.1 Ache Laboratorios Farmaceuticos Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.5.3 Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.5.4 Ache Laboratorios Farmaceuticos Business Overview
3.6 Mylan
3.6.1 Mylan Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.6.3 Mylan Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.6.4 Mylan Business Overview
3.7 Palobiofarma
3.7.1 Palobiofarma Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.7.3 Palobiofarma Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.7.4 Palobiofarma Business Overview
3.8 Innoviva
3.8.1 Innoviva Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.8.3 Innoviva Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.8.4 Innoviva Business Overview
3.9 Cytokinetics
3.9.1 Cytokinetics Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.9.3 Cytokinetics Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.9.4 Cytokinetics Business Overview
3.10 AstraZeneca
3.10.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.10.3 AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.10.4 AstraZeneca Business Overview
3.11 Prosonix
3.11.1 Prosonix Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.11.3 Prosonix Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.11.4 Prosonix Business Overview
3.12 Boehringer Ingelheim
3.12.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.12.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.12.4 Boehringer Ingelheim Business Overview
3.13 Novartis
3.13.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.13.3 Novartis Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.13.4 Novartis Business Overview
3.14 Merck
3.14.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.14.3 Merck Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.14.4 Merck Business Overview
3.15 Gilead Sciences
3.15.1 Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.15.3 Gilead Sciences Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.15.4 Gilead Sciences Business Overview
3.16 Mereo BioPharma
3.16.1 Mereo BioPharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.16.3 Mereo BioPharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.16.4 Mereo BioPharma Business Overview
3.17 Pearl Therapeutics
3.17.1 Pearl Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.17.3 Pearl Therapeutics Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.17.4 Pearl Therapeutics Business Overview
3.18 BioMarck Pharmaceuticals
3.18.1 BioMarck Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.18.3 BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.18.4 BioMarck Pharmaceuticals Business Overview
3.19 Orion Corporation
3.19.1 Orion Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.19.3 Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.19.4 Orion Corporation Business Overview
3.20 Pharmaxis
3.20.1 Pharmaxis Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.20.3 Pharmaxis Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.20.4 Pharmaxis Business Overview
3.21 Aquinox Pharmaceuticals
3.21.1 Aquinox Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.21.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.21.3 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.21.4 Aquinox Pharmaceuticals Business Overview
3.22 Astellas Pharma
3.22.1 Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.22.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.22.3 Astellas Pharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.22.4 Astellas Pharma Business Overview
3.23 ZAI Lab
3.23.1 ZAI Lab Basic Information, Manufacturing Base, Sales Area and Competitors
3.23.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.23.3 ZAI Lab Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.23.4 ZAI Lab Business Overview
3.24 Asmacure
3.24.1 Asmacure Basic Information, Manufacturing Base, Sales Area and Competitors
3.24.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.24.3 Asmacure Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.24.4 Asmacure Business Overview
3.25 Almirall
3.25.1 Almirall Basic Information, Manufacturing Base, Sales Area and Competitors
3.25.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.25.3 Almirall Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.25.4 Almirall Business Overview
3.26 Ario Pharma
3.26.1 Ario Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.26.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.26.3 Ario Pharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.26.4 Ario Pharma Business Overview
4 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and Market Share by Type (2014-2019)
4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Market Share by Type (2014-2019)
4.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Price by Type (2014-2019)
4.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate by Type (2014-2019)
4.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of anticholinergic (2014-2019)
4.4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of oral corticosteroid (2014-2019)
4.4.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of beta2-agonists (2014-2019)
4.4.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of phosphodiesterase-4 (PDE4) inhibitors (2014-2019)
4.4.5 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of others (2014-2019)
5 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DRUGS MARKET ANALYSIS BY APPLICATION
5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Market Share by Application (2014-2019)
5.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Growth Rate of lung functional test (2014-2019)
5.2.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Growth Rate of chest x-ray test (2014-2019)
5.2.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Growth Rate of CT scan (2014-2019)
5.2.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Growth Rate of others (2014-2019)
6 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DRUGS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption by Region (2014-2019)
6.2 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019)
6.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019)
6.4 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019)
6.5 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019)
6.6 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019)
7 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and Market Share by Region (2014-2019)
7.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
8 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DRUGS MANUFACTURING ANALYSIS
8.1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Chronic Obstructive Pulmonary Disease (COPD) Drugs
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Industrial Chain Analysis
9.2 Raw Materials Sources of Chronic Obstructive Pulmonary Disease (COPD) Drugs Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Chronic Obstructive Pulmonary Disease (COPD) Drugs
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter’s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DRUGS MARKET FORECAST (2019-2026)
11.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue Forecast (2019-2026)
11.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Price and Trend Forecast (2019-2026)
11.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Chronic Obstructive Pulmonary Disease (COPD) Drugs
1.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Segment by Type
1.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of anticholinergic
1.2.3 The Market Profile of oral corticosteroid
1.2.4 The Market Profile of beta2-agonists
1.2.5 The Market Profile of phosphodiesterase-4 (PDE4) inhibitors
1.2.6 The Market Profile of others
1.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Segment by Application
1.3.1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of lung functional test
1.3.3 The Market Profile of chest x-ray test
1.3.4 The Market Profile of CT scan
1.3.5 The Market Profile of others
1.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market by Region (2014-2026)
1.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.3.1 Germany Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.3.2 UK Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.3.3 France Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.3.4 Italy Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.3.5 Spain Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.3.6 Russia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.3.7 Poland Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.4 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.5 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.6 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.8 Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Chronic Obstructive Pulmonary Disease (COPD) Drugs (2014-2026)
1.5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Status and Outlook (2014-2026)
1.5.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Status and Outlook (2014-2026)
2 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DRUGS MARKET LANDSCAPE BY PLAYER
2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and Share by Player (2014-2019)
2.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Market Share by Player (2014-2019)
2.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Average Price by Player (2014-2019)
2.4 Chronic Obstructive Pulmonary Disease (COPD) Drugs Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Competitive Situation and Trends
2.5.1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Concentration Rate
2.5.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 MediciNova
3.1.1 MediciNova Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.1.3 MediciNova Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.1.4 MediciNova Business Overview
3.2 Chiesi Farmaceutici
3.2.1 Chiesi Farmaceutici Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.2.3 Chiesi Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.2.4 Chiesi Farmaceutici Business Overview
3.3 F. Hoffmann-La Roche
3.3.1 F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.3.3 F. Hoffmann-La Roche Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.3.4 F. Hoffmann-La Roche Business Overview
3.4 Invion
3.4.1 Invion Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.4.3 Invion Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.4.4 Invion Business Overview
3.5 Ache Laboratorios Farmaceuticos
3.5.1 Ache Laboratorios Farmaceuticos Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.5.3 Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.5.4 Ache Laboratorios Farmaceuticos Business Overview
3.6 Mylan
3.6.1 Mylan Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.6.3 Mylan Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.6.4 Mylan Business Overview
3.7 Palobiofarma
3.7.1 Palobiofarma Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.7.3 Palobiofarma Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.7.4 Palobiofarma Business Overview
3.8 Innoviva
3.8.1 Innoviva Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.8.3 Innoviva Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.8.4 Innoviva Business Overview
3.9 Cytokinetics
3.9.1 Cytokinetics Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.9.3 Cytokinetics Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.9.4 Cytokinetics Business Overview
3.10 AstraZeneca
3.10.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.10.3 AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.10.4 AstraZeneca Business Overview
3.11 Prosonix
3.11.1 Prosonix Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.11.3 Prosonix Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.11.4 Prosonix Business Overview
3.12 Boehringer Ingelheim
3.12.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.12.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.12.4 Boehringer Ingelheim Business Overview
3.13 Novartis
3.13.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.13.3 Novartis Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.13.4 Novartis Business Overview
3.14 Merck
3.14.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.14.3 Merck Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.14.4 Merck Business Overview
3.15 Gilead Sciences
3.15.1 Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.15.3 Gilead Sciences Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.15.4 Gilead Sciences Business Overview
3.16 Mereo BioPharma
3.16.1 Mereo BioPharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.16.3 Mereo BioPharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.16.4 Mereo BioPharma Business Overview
3.17 Pearl Therapeutics
3.17.1 Pearl Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.17.3 Pearl Therapeutics Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.17.4 Pearl Therapeutics Business Overview
3.18 BioMarck Pharmaceuticals
3.18.1 BioMarck Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.18.3 BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.18.4 BioMarck Pharmaceuticals Business Overview
3.19 Orion Corporation
3.19.1 Orion Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.19.3 Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.19.4 Orion Corporation Business Overview
3.20 Pharmaxis
3.20.1 Pharmaxis Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.20.3 Pharmaxis Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.20.4 Pharmaxis Business Overview
3.21 Aquinox Pharmaceuticals
3.21.1 Aquinox Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.21.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.21.3 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.21.4 Aquinox Pharmaceuticals Business Overview
3.22 Astellas Pharma
3.22.1 Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.22.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.22.3 Astellas Pharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.22.4 Astellas Pharma Business Overview
3.23 ZAI Lab
3.23.1 ZAI Lab Basic Information, Manufacturing Base, Sales Area and Competitors
3.23.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.23.3 ZAI Lab Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.23.4 ZAI Lab Business Overview
3.24 Asmacure
3.24.1 Asmacure Basic Information, Manufacturing Base, Sales Area and Competitors
3.24.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.24.3 Asmacure Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.24.4 Asmacure Business Overview
3.25 Almirall
3.25.1 Almirall Basic Information, Manufacturing Base, Sales Area and Competitors
3.25.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.25.3 Almirall Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.25.4 Almirall Business Overview
3.26 Ario Pharma
3.26.1 Ario Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.26.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification
3.26.3 Ario Pharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019)
3.26.4 Ario Pharma Business Overview
4 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and Market Share by Type (2014-2019)
4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Market Share by Type (2014-2019)
4.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Price by Type (2014-2019)
4.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate by Type (2014-2019)
4.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of anticholinergic (2014-2019)
4.4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of oral corticosteroid (2014-2019)
4.4.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of beta2-agonists (2014-2019)
4.4.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of phosphodiesterase-4 (PDE4) inhibitors (2014-2019)
4.4.5 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of others (2014-2019)
5 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DRUGS MARKET ANALYSIS BY APPLICATION
5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Market Share by Application (2014-2019)
5.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Growth Rate of lung functional test (2014-2019)
5.2.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Growth Rate of chest x-ray test (2014-2019)
5.2.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Growth Rate of CT scan (2014-2019)
5.2.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Growth Rate of others (2014-2019)
6 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DRUGS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption by Region (2014-2019)
6.2 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019)
6.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019)
6.4 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019)
6.5 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019)
6.6 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019)
7 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and Market Share by Region (2014-2019)
7.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
8 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DRUGS MANUFACTURING ANALYSIS
8.1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Chronic Obstructive Pulmonary Disease (COPD) Drugs
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Industrial Chain Analysis
9.2 Raw Materials Sources of Chronic Obstructive Pulmonary Disease (COPD) Drugs Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Chronic Obstructive Pulmonary Disease (COPD) Drugs
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter’s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DRUGS MARKET FORECAST (2019-2026)
11.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue Forecast (2019-2026)
11.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Price and Trend Forecast (2019-2026)
11.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Picture
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and CAGR (%) Comparison by Type
Table Profile of anticholinergic
Table Profile of oral corticosteroid
Table Profile of beta2-agonists
Table Profile of phosphodiesterase-4 (PDE4) inhibitors
Table Profile of others
Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption (Sales) Comparison by Application (2014-2026)
Table Profile of lung functional test
Table Profile of chest x-ray test
Table Profile of CT scan
Table Profile of others
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Size (Value) and CAGR (%) (2014-2026)
Figure United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Germany Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure UK Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure France Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Italy Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Spain Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Russia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Poland Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure China Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure India Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Malaysia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Singapore Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Philippines Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Indonesia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Thailand Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Vietnam Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Brazil Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Mexico Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Colombia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Saudi Arabia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure United Arab Emirates Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Turkey Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Egypt Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure South Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Nigeria Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Status and Outlook (2014-2026)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production by Player (2014-2019)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Share by Player (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Share by Player in 2018
Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue by Player (2014-2019)
Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Market Share by Player (2014-2019)
Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Price by Player (2014-2019)
Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Manufacturing Base Distribution and Sales Area by Player
Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Table MediciNova Profile
Table MediciNova Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Chiesi Farmaceutici Profile
Table Chiesi Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Profile
Table F. Hoffmann-La Roche Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Invion Profile
Table Invion Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Ache Laboratorios Farmaceuticos Profile
Table Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Mylan Profile
Table Mylan Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Palobiofarma Profile
Table Palobiofarma Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Innoviva Profile
Table Innoviva Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Cytokinetics Profile
Table Cytokinetics Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table AstraZeneca Profile
Table AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Prosonix Profile
Table Prosonix Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Novartis Profile
Table Novartis Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Merck Profile
Table Merck Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Gilead Sciences Profile
Table Gilead Sciences Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Mereo BioPharma Profile
Table Mereo BioPharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Pearl Therapeutics Profile
Table Pearl Therapeutics Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table BioMarck Pharmaceuticals Profile
Table BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Orion Corporation Profile
Table Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Pharmaxis Profile
Table Pharmaxis Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Aquinox Pharmaceuticals Profile
Table Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Astellas Pharma Profile
Table Astellas Pharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table ZAI Lab Profile
Table ZAI Lab Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Asmacure Profile
Table Asmacure Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Almirall Profile
Table Almirall Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Ario Pharma Profile
Table Ario Pharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production by Type (2014-2019)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Market Share by Type (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Market Share by Type in 2018
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue by Type (2014-2019)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Market Share by Type (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Market Share by Type in 2018
Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Price by Type (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of anticholinergic (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of oral corticosteroid (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of beta2-ago
Figure Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Picture
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and CAGR (%) Comparison by Type
Table Profile of anticholinergic
Table Profile of oral corticosteroid
Table Profile of beta2-agonists
Table Profile of phosphodiesterase-4 (PDE4) inhibitors
Table Profile of others
Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption (Sales) Comparison by Application (2014-2026)
Table Profile of lung functional test
Table Profile of chest x-ray test
Table Profile of CT scan
Table Profile of others
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Size (Value) and CAGR (%) (2014-2026)
Figure United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Germany Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure UK Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure France Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Italy Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Spain Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Russia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Poland Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure China Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure India Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Malaysia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Singapore Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Philippines Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Indonesia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Thailand Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Vietnam Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Brazil Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Mexico Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Colombia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Saudi Arabia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure United Arab Emirates Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Turkey Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Egypt Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure South Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Nigeria Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Status and Outlook (2014-2026)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production by Player (2014-2019)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Share by Player (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Share by Player in 2018
Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue by Player (2014-2019)
Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Market Share by Player (2014-2019)
Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Price by Player (2014-2019)
Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Manufacturing Base Distribution and Sales Area by Player
Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Table MediciNova Profile
Table MediciNova Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Chiesi Farmaceutici Profile
Table Chiesi Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Profile
Table F. Hoffmann-La Roche Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Invion Profile
Table Invion Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Ache Laboratorios Farmaceuticos Profile
Table Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Mylan Profile
Table Mylan Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Palobiofarma Profile
Table Palobiofarma Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Innoviva Profile
Table Innoviva Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Cytokinetics Profile
Table Cytokinetics Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table AstraZeneca Profile
Table AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Prosonix Profile
Table Prosonix Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Novartis Profile
Table Novartis Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Merck Profile
Table Merck Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Gilead Sciences Profile
Table Gilead Sciences Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Mereo BioPharma Profile
Table Mereo BioPharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Pearl Therapeutics Profile
Table Pearl Therapeutics Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table BioMarck Pharmaceuticals Profile
Table BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Orion Corporation Profile
Table Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Pharmaxis Profile
Table Pharmaxis Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Aquinox Pharmaceuticals Profile
Table Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Astellas Pharma Profile
Table Astellas Pharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table ZAI Lab Profile
Table ZAI Lab Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Asmacure Profile
Table Asmacure Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Almirall Profile
Table Almirall Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Ario Pharma Profile
Table Ario Pharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production by Type (2014-2019)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Market Share by Type (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Market Share by Type in 2018
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue by Type (2014-2019)
Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Market Share by Type (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Market Share by Type in 2018
Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Price by Type (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of anticholinergic (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of oral corticosteroid (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of beta2-ago
